Bristol-Myers Squibb Co
BMY · Healthcare · Pharmaceuticals
Updated 25 min ago · data delayed ≥15 min
Iconic Score
ProprietaryRanked #102 of 503 by Iconic Score · #14 of 59in its sector. IconicAlpha’s proprietary brand-intelligence metric — a blend of scale, market attention, and category leadership.
Iconic Profile
Bristol-Myers Squibb Co (BMY) is a leading global biopharmaceutical company focused on discovering, developing, and delivering innovative medicines for patients with serious diseases. With a market capitalization of $117.6 billion, the company has a strong position in the healthcare sector, particularly in oncology, immunology, and cardiovascular disease treatments. Bristol-Myers Squibb's robust pipeline and commitment to research and development enable it to address unmet medical needs and enhance patient outcomes. Its portfolio includes several blockbuster drugs, which contribute significantly to its revenue and market presence. The company's strategic collaborations and acquisitions further strengthen its capabilities and competitive edge, making it a key player in the evolving pharmaceutical landscape.
Enterprise tier: claim your logo to manage how your brand is represented.